Annual Retained Earnings
-$3.38 B
-$413.56 M-13.96%
December 31, 2024
Summary
- As of March 7, 2025, IBRX annual retained earnings is -$3.38 billion, with the most recent change of -$413.56 million (-13.96%) on December 31, 2024.
- During the last 3 years, IBRX annual retained earnings has fallen by -$1.41 billion (-72.04%).
- IBRX annual retained earnings is now -108.98% below its all-time high of -$1.62 billion, reached on December 31, 2020.
Performance
IBRX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$3.38 B
-$59.16 M-1.78%
December 31, 2024
Summary
- As of March 7, 2025, IBRX quarterly retained earnings is -$3.38 billion, with the most recent change of -$59.16 million (-1.78%) on December 31, 2024.
- Over the past year, IBRX quarterly retained earnings has dropped by -$59.16 million (-1.78%).
- IBRX quarterly retained earnings is now -108.98% below its all-time high of -$1.62 billion, reached on December 31, 2020.
Performance
IBRX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
IBRX Retained Earnings Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -14.0% | -1.8% |
3 y3 years | -72.0% | -1.8% |
5 y5 years | - | -1.8% |
IBRX Retained Earnings Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -72.0% | at low | -72.0% | at low |
5 y | 5-year | -109.0% | at low | -109.0% | at low |
alltime | all time | -109.0% | at low | -109.0% | at low |
ImmunityBio Retained Earnings History
Date | Annual | Quarterly |
---|---|---|
Dec 2024 | -$3.38 B(+14.0%) | -$3.38 B(+1.8%) |
Sep 2024 | - | -$3.32 B(+2.7%) |
Jun 2024 | - | -$3.23 B(+4.3%) |
Mar 2024 | - | -$3.10 B(+4.5%) |
Dec 2023 | -$2.96 B(+24.5%) | -$2.96 B(+8.6%) |
Sep 2023 | - | -$2.73 B(+3.6%) |
Jun 2023 | - | -$2.63 B(+5.5%) |
Mar 2023 | - | -$2.49 B(+4.9%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2022 | -$2.38 B(+21.2%) | -$2.38 B(+4.8%) |
Sep 2022 | - | -$2.27 B(+5.1%) |
Jun 2022 | - | -$2.16 B(+4.6%) |
Mar 2022 | - | -$2.06 B(+5.2%) |
Dec 2021 | -$1.96 B(+21.5%) | -$1.96 B(+4.9%) |
Sep 2021 | - | -$1.87 B(+4.9%) |
Jun 2021 | - | -$1.78 B(+5.2%) |
Mar 2021 | - | -$1.69 B(+4.9%) |
Dec 2020 | -$1.62 B | -$1.62 B |
FAQ
- What is ImmunityBio annual retained earnings?
- What is the all time high annual retained earnings for ImmunityBio?
- What is ImmunityBio annual retained earnings year-on-year change?
- What is ImmunityBio quarterly retained earnings?
- What is the all time high quarterly retained earnings for ImmunityBio?
- What is ImmunityBio quarterly retained earnings year-on-year change?
What is ImmunityBio annual retained earnings?
The current annual retained earnings of IBRX is -$3.38 B
What is the all time high annual retained earnings for ImmunityBio?
ImmunityBio all-time high annual retained earnings is -$1.62 B
What is ImmunityBio annual retained earnings year-on-year change?
Over the past year, IBRX annual retained earnings has changed by -$413.56 M (-13.96%)
What is ImmunityBio quarterly retained earnings?
The current quarterly retained earnings of IBRX is -$3.38 B
What is the all time high quarterly retained earnings for ImmunityBio?
ImmunityBio all-time high quarterly retained earnings is -$1.62 B
What is ImmunityBio quarterly retained earnings year-on-year change?
Over the past year, IBRX quarterly retained earnings has changed by -$59.16 M (-1.78%)